Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development
- 1 October 1985
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 6 (3) , 241-248
- https://doi.org/10.1007/bf01806775
Abstract
The levels of cyclic adenosine 3′:5′-monophosphate (cAMP) and cyclic guanosine 3′:5′-monophosphate (cGMP) were studied in dimethylbenz(a)anthracene (DMBA)-induced mammary tumors of Sprague-Dawley rats and in human breast cancer. In the rat carcinomas, these levels were significantly lower than in non-malignant tissues when calculated on the basis of DNA content, but higher (cAMP) or equal (cGMP) when calculated on the basis of weight. In human breast cancer the cyclic nucleotide levels were higher than in non-malignant tissues according to both methods of calculation. No correlation was found in human carcinomas between the cyclic nucleotide levels and mitotic index, nuclear grade, tumor size, or lymph node involvement. The rat tumors were subclassified according to state of differentiation, mitotic index, and state of development. Not all the sub-groups had cAMP levels different from normal values. Differences in cAMP levels between the sub-groups could not be correlated with tumor growth rates and/or mitotic index. Thus, cyclic nucleotides may not be useful in prognosis of breast cancer.This publication has 39 references indexed in Scilit:
- Regulation of cyclic adenosine 3′,5′-monophosphate in relation to growth of dimethylbenz[a]anthracene-induced mammary tumors in ratsCancer Letters, 1980
- Differential effects of cAMP and cGMP on in vitro epidermal cell growthExperimental Cell Research, 1979
- Cyclic AMP‐Binding Proteins: Inverse Relationship with Estrogen‐Receptors in Hormone‐Dependent Mammary Tumor RegressionEuropean Journal of Biochemistry, 1978
- Cyclic nucleotide concentrations in 1, 2-dimethylhydrazine and x-ray induced rat small intestinal cancerCancer Letters, 1978
- Adenosine 3’,5’-Cyclic Monophosphate and Guanosine 3’,5’-Cyclic Monophosphate Levels in Human Breast Cancer TissueOncology, 1977
- The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon.Journal of Clinical Investigation, 1976
- Intracellular cAMP levels in normal rat mammary gland and adenocarcinoma. In vivo vs in vitroLife Sciences, 1975
- Cyclic GMP and cyclic AMP levels in normal and transformed fibroblastsNature, 1974
- Cyclic AMP levels in fibroblasts: Relationship to growth rate and contact inhibition of growthBiochemical and Biophysical Research Communications, 1971
- An Improved Diphenylamine Method for the Estimation of Deoxyribonucleic AcidNature, 1965